Cited 87 times in
Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.